The global antithrombin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Antithrombin is defined as a form of protein found in human blood that plays a pivotal role in the stoppage of blood clotting. Antithrombin acts as a natural blood thinner and also finds its application in performing surgical procedures of the patients with low antithrombin levels. Thus, the growing application of antithrombin in various surgical procedures is likely to augment the market growth during the forecast period. Further, the lack of antithrombin may increase the risk of thromboembolism, which can result in extreme bleeding during surgical procedures. Antithrombin III is also used in extracorporeal membrane oxygenation during cardiopulmonary bypass. 

Further, antithrombin can be used for therapeutic purposes in various conditions such as cardiac surgeries, as well as in genetic medical conditions such as antithrombin deficiency. As per the data published by the American Society of Hematology 900,000 people in the US develop blood clots yearly, and they are accountable for approximately 100,000 casualties each year. Furthermore, according to the National Organization for Rare Disorders, every one person in 3,000 to 5,000 people in the US has Type I antithrombin deficiency. The increasing prevalence of blood clotting diseases result in an increased demand for the therapeutic usage of antithrombin. Thus, in these cases, some of the tests such as AT Activity and test of antithrombin antigen level are highly practiced by physicians. Inherited antithrombin deficiency and the acquired deficiency caused by other diseases are two main prominent risk factors for causing antithrombin deficiency.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Application 
• By Source
• By Dosage Form

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Grifols, S.A., CSL Ltd., and Takeda Pharmaceutical Co. Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Antithrombin Market Report by Segment

By Application 

• Therapeutic
• Research
• Diagnostics

By Source

• Human
• Goat Milk

By Dosage Form

• Lyophilized
• Liquid

Global Antithrombin Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa